Literature DB >> 1650295

cGMP inhibits the activity of single calcium channels in embryonic chick heart cells.

N Tohse1, N Sperelakis.   

Abstract

Effects of cGMP on the slow (L-type) Ca2+ channels of cultured chick embryonic cardiomyocytes were investigated by a cell-attached patch-clamp method. Superfusion of the single cells with 8-bromo-cGMP, a membrane-permeable derivative of cGMP, inhibited the single-channel activity. The cyclic nucleotide decreased, in a concentration-dependent manner, the ensemble averaged currents obtained from multichannel patches. 8-Bromo-cGMP (1 mM) completely abolished the currents (n = 8), whereas 0.1 mM only slightly decreased the currents (n = 4). The influence of cGMP on the characteristics of the single Ca2+ channels was examined using 0.3 mM 8-bromo-cGMP. Unit amplitude and slope conductance of the Ca2+ channel was not changed (25 pS in control versus 24 pS in the presence of cGMP). Analysis of single-channel kinetics showed that cGMP prolonged the slow time constant for the closed-time histogram (from 6.7 to 15.4 msec); the other time constants (for the open-time and closed-time histograms) were not affected. cGMP-induced inhibition of the Ca2+ channels may be mediated by cGMP-dependent protein kinase, because 8-bromo-cGMP is a potent activator of this protein kinase and does not stimulate cAMP hydrolysis. The present results suggest that cGMP opposes the effects of cAMP on the L-type Ca2+ channels in myocardial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650295     DOI: 10.1161/01.res.69.2.325

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

Review 1.  Muscarinic regulation of cardiac ion channels.

Authors:  Robert D Harvey; Andriy E Belevych
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 2.  Regulation of ion channels in myocardial cells and protection of ischemic myocardium.

Authors:  N Sperelakis; M Sunagawa; H Yokoshiki; T Seki; M Nakamura
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

3.  Cyclic GMP-mediated inhibition of L-type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells.

Authors:  N Tohse; H Nakaya; Y Takeda; M Kanno
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

4.  Comparative analysis of the kinetic characteristics of L-type calcium channels in cardiac cells of hibernators.

Authors:  A E Alekseev; N I Markevich; A F Korystova; A Terzic; Y M Kokoz
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

5.  Natriuretic peptide immunoreactivity in nerve structures and Purkinje fibres of human, pig and sheep hearts.

Authors:  M Hansson; A Eriksson; S Forsgren
Journal:  Histochem J       Date:  1997-04

6.  Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2017-03-29       Impact factor: 5.000

7.  The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest.

Authors:  E A Konorev; J Joseph; M M Tarpey; B Kalyanaraman
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

8.  Regulation of the calcium slow channel by cyclic GMP dependent protein kinase in chick heart cells.

Authors:  G E Haddad; N Sperelakis; G Bkaily
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

9.  Nitric oxide modulation of GABAergic synaptic transmission in mechanically isolated rat auditory cortical neurons.

Authors:  Jong-Ju Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

10.  Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle.

Authors:  T Ishibashi; M Hamaguchi; K Kato; T Kawada; H Ohta; H Sasage; S Imai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.